Antidepressants and antipsychotics in the long-term treatment of bipolar disorder

Journal of Clinical Psychiatry

Volumn 63, Issue SUPPL. 10, 2002, Pages 23-28

  Kusumakar, Vivek ^a  

^a IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PHENELZINE; RISPERIDONE; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

AGRANULOCYTOSIS; AKATHISIA; CHRONIC DISEASE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPOKINESIA; HYPOMANIA; LONG TERM CARE; MAINTENANCE THERAPY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL LITERATURE; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PRIORITY JOURNAL; REVIEW; SEIZURE; SIDE EFFECT; TARDIVE DYSKINESIA; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN;

AGRANULOCYTOSIS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; CLOZAPINE; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; LONG-TERM CARE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0036395707     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Egeland JA, Blumenthal RL, Nee J. et al. Reliability and relationship of various ages of onset criteria for major affective disorder. J Affect Disord 1987;12:159-165
2. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 2001;62:565-569
3. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000;61:804-808
4. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in prevention of affective episodes: a comparison of recurrent affective illness. Arch Gen Psychiatry 1973;29:420-425
5. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979;36:555-559
6. Quitkin FM, Kane J, Rifkin A, et al. Prophylactic lithium carbonate with and without imipramine for bipolar I patients: a double-blind study. Arch Gen Psychiatry 1981;38:902-907
7. Kane JM, Quitkin FM, Rifkin A, et al. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. Arch Gen Psychiatry 1982;39:1065-1069
8. Prien RF, Kupfer DJ, Mansky PA, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar disorders: report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984;41:1095-1104
9. Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994;55:391-393
10. Amsterdam JD, Garcia-España F, Fawcett J, et al. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:435-440
11. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152:1130-1138
12. Sachs GS. Use of clonazepam for bipolar affective disorder. J Clin Psychiatry 1990;51(5, suppl):31-34
13. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-135
14. Keck PE Jr, McElroy SL, Strakowski SM, et al. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 1996;57:147-151
15. Verdoux H, Gonzales B, Takei N, et al. A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients. J Affect Disord 1996;38:81-87
16. Sernyak MJ, Godleski LS, Griffin RA, et al. Chronic neuroleptic exposure in bipolar outpatients. J Clin Psychiatry 1997;58:193-195
17. Licht RW. Drug treatment of mania: a critical review. Acta Psychiatr Scand 1998;97:387-397
18. Gelenberg AJ, Hopkins HS. Antipsychotics in bipolar disorder. J Clin Psychiatry 1996;57(suppl 9):49-52
19. Littlejohn R, Leslie F. Cookson J. Depot antipsychotics in the prophylaxis of bipolar affective disorders. Br J Psychiatry 1994;165:827-829
20. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995;56:411-417
21. Frye MA, Ketter TA, Altshuler LL. et al. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord 1998;48:91-104
22. Zarate CA Jr, Tohen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry 1995;56:108-112
23. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and history of mania. Am J Psychiatry 1999;156:1164-1169
24. Ciapparelli A, Dell'Osso L, Pini S, et al. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study. J Clin Psychiatry 2000;61:329-334
25. Vieta E. Goikolea JM, Corbella B. et al. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 2001;62:818-825
26. Ghaemi SN, Sachs GS. Long-term risperidone treatment in bipolar disorder: 6-month follow up. Int Clin Psychopharmacol 1997;12:333-338
27. Sanger TM, Grundy SL, Gibson PJ, et al. Long-term olanzapine therapy in the treatment of bipolar 1 disorder: an open-label continuation phase study. J Clin Psychiatry 2001;62:273-281
28. Narendran R, Young CM, Valenti AM, et al. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. J Clin Psychiatry 2001;62:509-516
29. Vieta E, Reinares M. Corbella B, et al. Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. J Clin Psychopharmacol 2001;21:469-473
30. Tohen MF, Chengappa KNR, Suppes P, et al. Olanzapine combined with lithium or valproate for relapse prevention of bipolar disorder: an 18-month study. Presented at the 155th annual meeting of the American Psychiatric Association; May 18-26, 2002; Philadelphia, Pa
31. Kane JM. Tardive dyskinesia in affective disorders. J Clin Psychiatry 1999;60(suppl 5):43-47
32. Mukherjee S, Rosen AM, Caracci G, et al. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986;43:342-346
33. Ghadirian AM, Annable L, Bélanger MC, et al. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affected disordered patients. J Clin Psychiatry 1996;57:22-29
34. Zarate CA Jr. Antipsychotic drug side effect issues in bipolar manic patients. J Clin Psychiatry 2000;61(suppl 8):52-61
35. Allison DB, Mentore JL, Heo M. et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-1696